Table 1.
| |||||
---|---|---|---|---|---|
Entry | AA1 = | Ligation product | Product peak areac / % | Mass yield (from resin) | Isolated yieldd / % |
1 | Ser | Fmoc-Phe–Ser-Asp-Tyr-Lys-Ala-NH2 | 55% (220 nm) | 4.8 mg from 49.4 mg 12a | 22 |
2b | Ser | Fmoc-Phe–Ser-Asp-Tyr-Lys-Ala-NH2 | 37% (220 nm) | not determined | not determined |
3 | Glu | Fmoc-Phe–Glu-Asp-Tyr-Lys-Ala-NH2 | 41% (220 nm) | 6.8 mg from 6.2 mg 12b | 25 |
4 | Phe | Fmoc-Phe–Phe-Asp-Tyr-Lys-Ala-NH2 | 42% (220 nm) | 5.1 mg from 64.6 mg 12c | 17 |
5 | Ala | Fmoc-Phe–Ala-Asp-Tyr-Lys-Ala-NH2 | 47% (220 nm) | 2.9 mg from 32.9 mg 12d | 18 |
6 | Leu | Fmoc-Phe–Leu-Lys-Ser-Glu-Tyr-NH2 | 31% (220 nm) | 3.4 mg from 38.7 mg 12e | 20 |
See Supporting Information for further experimental details.
(±)-1 was used.
Determined by HPLC analyses of unpurified peptides following cleavage.
Approximate yields over entire sequence based on mass recovery of the ligated peptide following preparative HPLC.